117 related articles for article (PubMed ID: 4069122)
21. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
22. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. II. Separation of natural killer cells and cytotoxic T cells.
Le Gros GS; Herbert AG; Watson JD
Immunology; 1984 Jan; 51(1):103-13. PubMed ID: 6606615
[TBL] [Abstract][Full Text] [Related]
23. [NK activity in C57BL/Ka mice during the development of radiation-induced lymphomas].
Noël A; Schaaf-Lafontaine N; Defresne MP; Boniver J
C R Seances Soc Biol Fil; 1985; 179(2):271-5. PubMed ID: 3160448
[TBL] [Abstract][Full Text] [Related]
24. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
25. Inhibitor cells in spleens of mice with low natural killer activity.
Blair PB; Staskawicz MO; Sam JS
J Natl Cancer Inst; 1983 Sep; 71(3):571-7. PubMed ID: 6577231
[TBL] [Abstract][Full Text] [Related]
26. Suppression of natural killer cell activity in infant mice occurs after target cell binding.
Dussault I; Miller SC
Nat Immun; 1995; 14(1):35-43. PubMed ID: 7599460
[TBL] [Abstract][Full Text] [Related]
27. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.
Habu S; Fukui H; Shimamura K; Kasai M; Nagai Y; Okumura K; Tamaoki N
J Immunol; 1981 Jul; 127(1):34-8. PubMed ID: 7240748
[TBL] [Abstract][Full Text] [Related]
28. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
Ellison CA; MacDonald GC; Rector ES; Gartner JG
J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
[TBL] [Abstract][Full Text] [Related]
29. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
Pattengale PK; Sundstrom C; Yu AL; Levine A
Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
[TBL] [Abstract][Full Text] [Related]
30. Increased natural killer cell activity in experimental American trypanosomiasis.
Hatcher FM; Kuhn RE; Cerrone MC; Burton RC
J Immunol; 1981 Sep; 127(3):1126-30. PubMed ID: 6790614
[TBL] [Abstract][Full Text] [Related]
31. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the activity of mouse natural killer cells by urethan.
Gorelik E; Herberman RB
J Natl Cancer Inst; 1981 Mar; 66(3):543-8. PubMed ID: 6937709
[TBL] [Abstract][Full Text] [Related]
33. Augmentation of natural killer cell activity in spleens of infant, aged, and low responder strain mice by Corynebacterium parvum.
Gallagher MT; Nasrallah AG; Datta SK; Priest EL; Trentin JJ
Exp Hematol; 1981 Feb; 9(2):149-55. PubMed ID: 7238649
[TBL] [Abstract][Full Text] [Related]
34. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
35. Depression of natural killer activity and mitogen responsiveness in mice treated with pristane.
Freund YR; Blair PB
J Immunol; 1982 Dec; 129(6):2826-30. PubMed ID: 7142708
[TBL] [Abstract][Full Text] [Related]
36. Murine lymph node natural killer cells: regulatory mechanisms of activation or suppression.
Hisano G; Hanna N
J Natl Cancer Inst; 1982 Sep; 69(3):665-71. PubMed ID: 6180211
[TBL] [Abstract][Full Text] [Related]
37. The effects of methylnitrosourea (MNU) on natural killer (NK) cell cytotoxicity and cytokine production in rats.
Talcott PA; Exon JH; Koller LD
Carcinogenesis; 1990 May; 11(5):829-34. PubMed ID: 2185903
[TBL] [Abstract][Full Text] [Related]
38. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
Xun CQ; Thompson JS; Jennings CD; Brown SA
Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
[TBL] [Abstract][Full Text] [Related]
39. Changes in natural killer cells activity in mice bearing subcutaneously implanted Lewis lung carcinoma.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1984; 32(2):185-9. PubMed ID: 6487051
[TBL] [Abstract][Full Text] [Related]
40. Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen.
Morelli L; Lemieux S
J Immunol; 1993 Dec; 151(12):6783-93. PubMed ID: 8258690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
